BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adeyanju OA, Michael OS, Soladoye AO, Olatunji LA. Blockade of mineralocorticoid receptor ameliorates oral contraceptive-induced insulin resistance by suppressing elevated uric acid and glycogen synthase kinase-3 instead of circulating mineralocorticoid. Archives of Physiology and Biochemistry 2020;126:225-34. [DOI: 10.1080/13813455.2018.1509220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Adeyanju OA, Falodun TO, Fabunmi OA, Olatunji LA, Soladoye AO. Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone. Chem Biol Interact 2019;310:108742. [PMID: 31295448 DOI: 10.1016/j.cbi.2019.108742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Adeyanju OA, Olatunji LA. Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone. J Basic Clin Physiol Pharmacol 2019;30. [PMID: 31469652 DOI: 10.1515/jbcpp-2018-0184] [Reference Citation Analysis]
3 Zhou Y, Lan H, Dong Z, Li W, Qian B, Zeng Z, He W, Song J, Mendoza-núñez VM. Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole-Induced Experimental Polycystic Ovary Syndrome. Oxidative Medicine and Cellular Longevity 2022;2022:1-18. [DOI: 10.1155/2022/5558599] [Reference Citation Analysis]
4 Adeyanju OA, Soetan OA, Olatunji LA. Drospirenone-containing contraceptive exerts positive effects on cardiac uric acid and PAI-1 but not GSK-3: Improved safety profiles in contraception? Pathophysiology 2019;26:227-31. [PMID: 31196791 DOI: 10.1016/j.pathophys.2019.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Adeyanju OA, Falodun TO, Michael OS, Soetan OA, Oyewole AL, Agbana RD. Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid-a familiar foe. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1055-66. [PMID: 31925474 DOI: 10.1007/s00210-020-01809-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Badmus OO, Areola ED, Benjamin E, Obekpa MA, Adegoke TE, Elijah OE, Imam A, Olajide OJ, Olatunji LA. Suppression of Adenosine Deaminase and Xanthine Oxidase Activities by Mineralocorticoid and Glucocorticoid Receptor Blockades Restores Renal Antioxidative Barrier in Oral Contraceptive-Treated Dam. J Renin Angiotensin Aldosterone Syst 2021;2021:9966372. [PMID: 34285713 DOI: 10.1155/2021/9966372] [Reference Citation Analysis]
7 Olaniyi KS, Oniyide AA, Adeyanju OA, Ojulari LS, Omoaghe AO, Olaiya OE. Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS. Toxicol Appl Pharmacol 2021;411:115381. [PMID: 33359182 DOI: 10.1016/j.taap.2020.115381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]